Latest Articles

Publication Date
Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies - Il Sole 24 ORE

Cervical, endometrial and urothelial cancers, how immunotherapy changes treatment strategies Il Sole 24 ORE

Published: Feb. 5, 2026, 10:31 a.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace

Published: Feb. 4, 2026, 4:47 a.m.
Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer - TradingView

Gsk - Quebec To Reimburse Jemperli Plus Chemotherapy Via Ramq For Primary Advanced/First Recurrent Endometrial Cancer TradingView

Published: Feb. 3, 2026, 1:11 p.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Newswire Canada

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Newswire …

Published: Feb. 3, 2026, 1 p.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Yahoo Finance Singapore

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Yahoo …

Published: Feb. 3, 2026, 1 p.m.
A new cell therapy shows promising results in women with Asherman síndrome - Vall d'Hebron Barcelona Hospital Campus

A new cell therapy shows promising results in women with Asherman síndrome Vall d'Hebron Barcelona Hospital Campus

Published: Feb. 2, 2026, 8:10 a.m.
How Immunotherapy Helps Women With Advanced Endometrial Cancer - Banner Health

How Immunotherapy Helps Women With Advanced Endometrial Cancer Banner Health

Published: Jan. 28, 2026, 7:05 p.m.
Immunotherapy and Targeted Strategies Reshape Endometrial Cancer Care at New Jersey Prominent Trial Site - trialsitenews.com

Immunotherapy and Targeted Strategies Reshape Endometrial Cancer Care at New Jersey Prominent Trial Site trialsitenews.com

Published: Jan. 25, 2026, 7:10 a.m.
Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery - Cureus

Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery Cureus

Published: Jan. 21, 2026, 1:51 p.m.
Uterine transposition clears the field for radiation therapy - Cleveland Clinic

Uterine transposition clears the field for radiation therapy Cleveland Clinic

Published: Jan. 21, 2026, 5:45 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!